Deals
Filed: CVC, GBL Bid €10.7B to Delist Recordati
CVC and GBL bid €10.7B to take Recordati private, but a 13% premium to the March price is a thin ask when you already control the register.
Latest — Page 29
FDA
Ousted: Biohaven Ran the Campaign Against Makary
Biohaven's CEO and other biotech leaders quietly lobbied the White House to push out FDA's Makary after troriluzole's November CRL.
Deals
EU Reviews MiCA Two Years In; Dollar Stablecoins Win
Europe's flagship crypto framework is barely two years old, and Brussels is already asking if it can survive dollar stablecoins' global grip.
AI
Signed: Newsom Mandates AI Workforce Tracking, 33 Firms
California's first AI workforce EO lands the day the White House cancelled its own. For 33 top private AI firms, the rules are moving now.
Legal
Seized: First VPN, 25 Ransomware Gangs Exposed
When Europol obtained First VPN's user database, it told every client they'd been identified. Now 25 ransomware gangs know their cover is gone.
Legal
Signed May 19: Trump EO Puts Fed Master Accounts in Play
Trump's May 19 EO gives the Fed 120 days to weigh fintech access to payment rails. The master account question finally has a clock.
AI
Deepfakes Drained $25.6M from Arup in One Call
Arup's finance team verified a $25.6M wire over live video, where every face they saw was AI-generated. That video call was the attack.
Legal
Ukraine IDs 18-Year-Old Behind $721K Account Theft
Ukrainian cyberpolice identified the Odesa teen on May 12: he ran the infrastructure behind $721K in unauthorized purchases from 28,000 accounts.
Legal
Breached: 3,800 GitHub Repos Stolen via 18-Min Extension
TeamPCP stole 3,800 GitHub internal repos via a poisoned VS Code extension live for just 18 minutes, now demanding at least $50K for the data.
Deals
Lilly Bought Engage Bio's DNA Platform for $202M
Eli Lilly paid up to $202M for a preclinical biotech with zero disclosed programs: the platform bet driving its $21B 2026 buying spree.
AI
Apple Stopped $2.2B in App Store Fraud in 2025
Apple stopped $2.2B in App Store fraud in 2025, rejected 1.1 billion fake account creations, and now sits at $11.2B blocked over six years.
Legal
Fined $1M, Yotta Customers Still Out Millions
California's first-ever Yotta penalty is $1M, but the 18,000 California customers still waiting for Synapse restitution call it a rounding error.
FDA
Bimzelx Beats Skyrizi 49% to 38% on ACR50 in PsA Trial
BE BOLD's Phase 3 data put a 10-point ACR50 gap between Bimzelx and Skyrizi, the $17.56B drug AbbVie built its post-Humira franchise on.
Deals
Immunovant Paid $39M to Exit Batoclimab After TED Fails
Immunovant paid $39M in exit costs on batoclimab after two phase 3 TED trial failures, while next-gen IMVT-1402 RA data lifted shares 20%.
Legal
SEC Clears Methode Electronics After Dual Subpoenas
SEC closed its FCPA probe of Methode Electronics with no enforcement action, after two subpoenas covering executive pay and hotline tips.
